DMK Group appoints new COO for the Industry business unit
Vlaar joins from Centrient Pharmaceuticals, a Netherlands-based global business-to-business leader in sustainable generic pharmaceuticals. There he was most recently responsible as Chief Commercial Officer and a member of the Executive Leadership Team. He holds a master's degree in chemical engineering, is considered an experienced manager and brings many years of expertise in general management, strategy, commercial excellence and innovation management.
Ingo Müller, CEO of DMK Group:"We are delighted to have gained an extremely accomplished manager for this position in Frans Vlaar. With his extensive know-how, he will be able to give the Industry Business Unit significant impetus on its way forward. I have come to know Frans Vlaar as a positive personality and team player with the ability to convince in global teams. I wish him every success in his new role at DMK Group and look forward to a trusting and successful collaboration." In this context, Müller expressed his thanks to Martin Humfeldt (Director Operations BU Industry) and Sierk Weisser Krepetin (Director Sales BU Industry). Both will report to Vlaar in future and have managed the BU on an interim basis. Müller: They were immediately willing to walk this personal "extra mile" for the company and their industry teams."
"B2B is an extremely exciting business field for me because you can develop the right solution for customers together with them. Working in this area also means actively shaping tomorrow's market and thinking about new trends and developments at an early stage. The BU Industry plays an important role in the DMK Group's mission statement 2030 - the tasks that await me there allow me to apply my many years of experience in an exciting working environment and forward-looking company,"explains Vlaar.